Access cutting-edge acute coronary syndrome treatment through this clinical trial at a research site in Huntsville. Study-provided care at no cost to qualified participants.
Access acute coronary syndrome specialists in Huntsville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute coronary syndrome treatment provided free
This is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic profile. Subjects will provide informed consent before any study-specific procedures are performed. A separate informed consent will be allowed for an initial pre-screening genetic testing. Subjects meeting the AA genotype will then consent to the full study and confirmatory genetic testing as required. Subject enrollment may
Sponsor: DalCor Pharmaceuticals
Check if you qualify for this acute coronary syndrome clinical trial in Huntsville, AL
If you're searching for acute coronary syndrome treatment options in Huntsville, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Huntsville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute coronary syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.